Apogenix And EMA To Settle On Phase III Plans For PRIME Candidate Asunercept

 
• By Neena Brizmohun
  
Tumour
Apogenix and EU regulators are to discuss the next steps for the company's glioblastoma drug • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet